ArticleJournal of neurology2025
Global, regional, and national epidemiology of ischemic stroke in young adults, 1990-2021.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Targeting Neuroinflammation in Adult Ischemic Stroke: Direct Immunotherapy, Regenerative Cell-Based Strategies, and Translational Challenges-A Systematic Review with Exploratory Meta-analysis.Molecular neurobiology · 2026Pooled it
- Prevalence of anxiety and depression in young stroke patients, and associated factors: a meta-analysis.Frontiers in neurologyPooled it
- Global trend and disparity in the burden of ischemic stroke attributable to high body-mass index from 1990 to 2021 and projection to 2050: a systematic analysis based on the Global Burden of Disease Study 2021.Dialogues in health · 2026Article
- Identification of a novel metabolic and lipidomic signature for 90-day functional outcome after ischemic stroke: an exploratory proof-of-concept study.Frontiers in neurology · 2026Article
- Verbascoside (VB) Inhibits Ischemic Stroke Progression via Suppression of Cell Damage and Ferroptosis By Targeting LCN2/ALOX5/SLC7A11/GPX4 Expression.Molecular neurobiology · 2025Article
- Association between the psychological frailty index and stroke: a cohort study from CHARLS.Scientific reports · 2025Article
- Level of discharge readiness and influencing factors in ischaemic stroke patients: a descriptive, cross-sectional study.Frontiers in neurology · 2025Article
- The global burden of hypertension and its epidemiological impacts on adolescents and young adults: projections to 2050.Frontiers in cardiovascular medicine · 2025Article
- Neuroprotective effect of resveratrol on Epac-1/Rap-1 signaling pathway in ischemic stroke rats.Frontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionThis study, for the first time, utilizes the 2021 GBD data to analyze the disease burden of ischemic stroke in young adults (defined as aged 20-50 years) globally, aiming to provide a scientific basis for public health interventions.
methodsThe study employs GBD data from 1990 to 2021 to analyze the incidence, mortality, and disability-adjusted life years (DALYs) of ischemic stroke in young adults. We assess differences in disease burden across regions with varying levels of socioeconomic development using the Sociodemographic Index (SDI). We also utilize Joinpoint regression and the Bayesian Age-Period-Cohort (BAPC) model to analyze temporal trends and predict future burdens. Additionally, we examine the distribution of ischemic stroke in young adults across different ages, genders, and regions.
resultsIn 2021, the number of deaths and incidences increased; however, the age-standardized mortality rate decreased. The Middle SDI region had the highest number of deaths and incidence, while the High SDI region had the lowest number of deaths. Southeast Asia had the highest estimated annual percentage change (EAPC) in mortality Age-Standardized Rate (ASR), East Asia had the highest EAPC in incidence ASR. The incidence was highest in the age group of 40-49 years, with a shift from older to middle-aged populations. The mortality rate in males was generally higher than in females. The age-standardized incidence rate of ischemic stroke in young adults is expected to continue declining in the future, while the number of cases is likely to keep increasing.
conclusionDespite a global decline of mortality and incidence in all SDI regions, the disease burden continues to rise due to population growth and aging, especially in Middle SDI regions. The study predicts ongoing increases in disease burden, highlighting the impact of gender and socioeconomic factors. Further research is needed to prevent the disease from affecting younger populations.
Indexed as
Identifiers
40261367What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.